@article{zheng2020bi,
  title={Bi-maml: Balanced incremental approach for meta learning},
  author={Zheng, Yang and Xiang, Jinlin and Su, Kun and Shlizerman, Eli},
  journal={arXiv preprint arXiv:2006.07412},
  year={2020},
  arxiv={2006.07412},
  bibtex_show={true},
  supp={https://www.youtube.com/watch?v=4qlb-iG5SFo}
}

@InProceedings{10.1007/978-3-031-18523-6_1,
abbr={MICCAI-DECAF},
author={You, Chenyu
and Xiang, Jinlin
and Su, Kun
and Zhang, Xiaoran
and Dong, Siyuan
and Onofrey, John
and Staib, Lawrence
and Duncan, James S.},
title={Incremental Learning Meets Transfer Learning: Application to Multi-site Prostate MRI Segmentation},
booktitle={Distributed, Collaborative, and Federated Learning, and Affordable AI and Healthcare for Resource Diverse Global Health},
year={2022},
publisher={Springer Nature Switzerland},
address={Cham},
pages={3--16},
isbn={978-3-031-18523-6},
code={https://github.com/sukun1045/IL_medical_segmentation},
selected= true
}

@article{xiang2022knowledge,
  abbr={Applied Optics},
  title={Knowledge distillation circumvents nonlinearity for optical convolutional neural networks},
  author={Xiang, Jinlin and Colburn, Shane and Majumdar, Arka and Shlizerman, Eli},
  journal={Applied Optics},
  volume={61},
  number={9},
  pages={2173--2183},
  year={2022},
  publisher={Optica Publishing Group},
  html={https://opg.optica.org/ao/viewmedia.cfm?uri=ao-61-9-2173},
  code={https://github.com/shlizee/SCLCKDTraining},
  selected= true
}
@inproceedings{xiang2023tkil,
  abbr={ICCV},
  title={TKIL: Tangent Kernel Optimization for Class Balanced Incremental Learning},
  author={Xiang, Jinlin and Shlizerman, Eli},
  booktitle={Proceedings of the IEEE/CVF International Conference on Computer Vision},
  pages={3529--3539},
  year={2023},
  poster={https://wvcl.vis.xyz/posters/p28.pdf},
  selected= true
}

@inproceedings{xiang2023data,
  abbr = {NeurIPS DLDE},
  title={Data-Driven Neural-ODE Modeling for Breast Cancer Tumor Dynamics and Progression-Free Survival Predictions},
  author={Xiang, Jinlin and Qi, Bozhao and Tang, Qi and Cerou, Marc and Zhao, Wei},
  booktitle={The Symbiosis of Deep Learning and Differential Equations III},
  year={2023},
  poster={https://neurips.cc/virtual/2023/75464}
}

@article{wu2023driver,
  abbr = {IEEE},
  title={Driver's Hand-Foot Coordination and Global-Regional Brain Functional Connectivity under Fatigue: Via Graph Theory and Explainable Artificial Intelligence},
  author={Wu, Yingzhang and Li, Wenbo and Zhang, Jie and Tang, Bangbei and Xiang, Jinlin and Li, Shen and Guo, Gang},
  journal={IEEE Transactions on Intelligent Vehicles},
  year={2023},
  publisher={IEEE},
  selected= true
}

@article{XIANG2024108876,
abbr = {CIBM},
title = {DN-ODE: Data-driven neural-ODE modeling for breast cancer tumor dynamics and progression-free survivals},
journal = {Computers in Biology and Medicine},
volume = {180},
pages = {108876},
year = {2024},
issn = {0010-4825},
doi = {https://doi.org/10.1016/j.compbiomed.2024.108876},
url = {https://www.sciencedirect.com/science/article/pii/S0010482524009612},
author = {Jinlin Xiang and Bozhao Qi and Marc Cerou and Wei Zhao and Qi Tang},
keywords = {Neural ordinary differential equation, Tumor dynamics, Progression free survival, PK/PD modeling},
abstract = {Pharmacokinetic/Pharmacodynamic (PK/PD) modeling is crucial in the development of new drugs. However, traditional population-based PK/PD models encounter challenges when modeling for individual patients. We aim to explore the potential of constructing a pharmacodynamic model for individual breast cancer pharmacodynamics leveraging only limited data from early clinical trial phases. While previous studies on Neural Ordinary Differential Equations (ODEs) suggest promising results in clinical trial practices, they primarily focused on theoretical applications or independent PK/PD modeling. PD modeling from complex and irregular clinical trial data, especially when interacting with PK parameters, is still unclear. To achieve that, we introduce a Data-driven Neural Ordinary Differential Equation (DN-ODE) modeling for breast cancer tumor dynamics and progression-free survival data. To validate this approach, experiments are conducted with early-phase clinical trial data from the Amcenestrant (an oral treatment for breast cancer) dataset (AMEERA 1-2), aiming to predict pharmacodynamics in the later phase (AMEERA 3). DN-ODE model achieves RMSE scores of 8.78 and 0.21 in tumor size and progression-free survival, respectively, with R2 scores over 0.9 for each task. Compared to PK/PD methodologies, DN-ODE is able to predict robust individual tumor dynamics with only limited cycle data. We also introduce Principal Component Analysis visualizations for encoder results, demonstrating the DN-ODEâ€™s capability to discern individual distributions and diverse tumor growth patterns. Therefore, DN-ODE facilitates comprehensive drug efficacy assessments, pinpoints potential responders, and aids in trial design.},
selected= true
}